CIK 0001621227 · Non-accelerated filer<br>Smaller reporting company
Adaptimmune Therapeutics PLC
Sign in to watch- Ticker
- ADAPY
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 44 1235 430000
- Business address
- 60 JUBILEE AVENUE, MILTON PARK, ABINGDON, OXFORDSHIRE, United Kingdom
- Former names
- Adaptimmune Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 10 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-17 | Lunger John Chief Patient Supply Officer | Sale | −5,584 | $0.58 | $3K | 7,510 |
| 2025-01-17 | Bertrand William C JR Chief Operating Officer | Sale | −5,584 | $0.58 | $3K | 7,510 |
| 2025-01-17 | Rawcliffe Adrian Chief Executive Officer | Sale | −30,601 | $0.58 | $18K | 44,327 |
| 2025-01-15 | Rawcliffe Adrian Chief Executive Officer | Sale | −29,096 | $0.57 | $17K | 41,582 |
| 2025-01-15 | Piccina Cintia Chief Commercial Officer | Sale | −12,991 | $0.57 | $7K | 18,421 |
| 2025-01-15 | Norry Elliot Chief Medical Officer | Sale | −9,803 | $0.57 | $6K | 13,756 |
| 2025-01-15 | Lunger John Chief Patient Supply Officer | Sale | −9,803 | $0.57 | $6K | 13,756 |
| 2025-01-15 | Bertrand William C JR Chief Operating Officer | Sale | −9,803 | $0.57 | $6K | 13,756 |
| 2025-01-13 | Rawcliffe Adrian Chief Executive Officer | Sale | −12,539 | $0.59 | $7K | 17,801 |
| 2025-01-13 | Rawcliffe Adrian Chief Executive Officer | Sale | −17,934 | $0.59 | $11K | 25,711 |
| 2025-01-13 | Norry Elliot Chief Medical Officer | Sale | −4,268 | $0.59 | $3K | 5,845 |
| 2025-01-13 | Norry Elliot Chief Medical Officer | Sale | −8,124 | $0.59 | $5K | 11,516 |
| 2025-01-13 | Lunger John Chief Patient Supply Officer | Sale | −4,268 | $0.59 | $3K | 5,845 |
| 2025-01-13 | Lunger John Chief Patient Supply Officer | Sale | −5,471 | $0.59 | $3K | 7,623 |
| 2025-01-13 | Bertrand William C JR Chief Operating Officer | Sale | −4,268 | $0.59 | $3K | 5,845 |
| 2025-01-13 | Bertrand William C JR Chief Operating Officer | Sale | −5,471 | $0.59 | $3K | 7,623 |
| 2024-07-01 | MOTT DAVID M Director | Grant or award · Option to purchase Ordinary Shares | +1,583,214 | 1,583,214 | ||
| 2024-07-01 | Menzel Garry E Director | Grant or award · Option to purchase Ordinary Shares | +1,121,604 | 1,121,604 | ||
| 2024-07-01 | Hege Kristen Director | Grant or award · Option to purchase Ordinary Shares | +660,000 | 660,000 | ||
| 2024-07-01 | Hegde Priti Director | Grant or award · Option to purchase Ordinary Shares | +1,144,686 | 1,144,686 |
Page 2 of 23 · 454 trades